# A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

> **NCT05865496** · PHASE2 · UNKNOWN · sponsor: **Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.** · enrollment: 90 (estimated)

## Conditions studied

- Sinusitis
- Nasal Polyps
- Polyps

## Interventions

- **DRUG:** 611
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05865496
- **Lead sponsor:** Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-30
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05865496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05865496, "A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05865496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*